Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care. [NA]
The ADDITION trial update reports results of intensive treatment in people with screen-detected Type 2 diabetes in primary care.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Effects of 5-Aminolevulinic Acid on Glucose Metabolism [NA]
A completed study evaluated the effects of 5-aminolevulinic acid on glucose metabolism in adults with type 2 diabetes mellitus who were on m…
-
FDA approval · 2013-12-18FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial comparing insulin intensification therapies in Type 2 diabetes has completed, with results posted in 2013.
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT) [NA]
A clinical trial update from Vanderbilt University about enhancing a randomized controlled trial for situational problem solving in adolesce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing basal insulin glargine with exenatide versus basal insulin glargine with bolus insulin lispro, both with metformin, …
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: GLP-1 and Non-exercise Activity Thermogenesis in RHZ [Phase 4]
Phase 4 clinical trial update reports termination of a study examining GLP-1–related effects on non-exercise activity thermogenesis in patie…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 study assessing the safety, pharmacokinetics, and pharmacodynamics of CNTO 3649 in healthy adults and patients with Type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans [NA]
Completed clinical trial evaluating the effect of dietary advanced glycation end-products on insulin resistance in overweight and obese adul…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes [NA]
This clinical trial update reports on a completed study evaluating the effects of pistachios on cardiovascular responses to stress in indivi…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM [Phase 4]
Phase 4 study investigating the glucose-lowering mechanisms of sitagliptin and metformin, alone and in combination, in adults with type 2 di…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration [Phase 1]
Phase 1 bioequivalence study comparing the fixed-dose combination Saxagliptin/metformin XR to co-administration in adults with Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
A completed study evaluated cholesterol profiles, lipoprotein types, and apolipoprotein levels in African Americans with Type 2 Diabetes, wi…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Multicentric Evaluation of Two Telematics Systems in Type 2 Diabetic Patients in Failure of Oral Treatment and Having to Start Treatment by Basal Insulin [NA]
This is a multicenter evaluation of two telematics systems in patients with Type 2 diabetes who failed oral therapy and started basal insuli…
-
FDA approval · 2013-12-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly, granting a supplemental approval to the existing biolo…
-
FDA approval · 2013-12-12FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update reporting results for multiple oral doses of JNJ-41443532 in patients with type 2 diabetes mellitus; results w…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes [Phase 4]
Phase 4 trial comparing continuous subcutaneous insulin infusion (CSII) with basal-bolus multiple daily injections in type 2 diabetes to ass…
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice [NA]
An update on new approaches to optimize medical care for Type 2 diabetes mellitus in general practice; the study status shows as completed.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes
This clinical trial assessing ambulatory pulse wave velocity and central augmentation index in people with type 2 diabetes mellitus has comp…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007) [Phase 2]
This Phase 2 dose-ranging study of MK0736 in patients with type 2 diabetes mellitus and hypertension was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: The Effect of GLP-1 on the Inhibition of Glucagon Secretion [NA]
A completed clinical trial evaluating the effect of GLP-1 on glucagon secretion in people with Type 1 diabetes mellitus and Type 2 diabetes …
-
FDA approval · 2013-12-09FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company. This confirms regulatory approval …
-
FDA approval · 2013-12-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2013-12-05Clinical Trial Update: Marathon Runners Compared to Sedentary Matched Control Subjects
A clinical trial update comparing marathon runners to sedentary matched control subjects in individuals with Type 2 Diabetes.